Measles resurgence due to vaccination coverage gaps, according to WHO
A WHO report has indicated that measles cases spiked globally due to gaps in vaccination coverage, as many countries experienced severe outbreaks.
Browsing: Vaccines
FDA grants priority review for controversial dengue vaccine, Dengvaxia
The US FDA has granted priority review for Sanofi Pasteur’s dengue vaccine, Dengvaxia®, despite its controversial past.
Oral cholera vaccination to be administered to 1.4 million in Zimbabwe’s capital
The WHO are amongst those aiding the Government of Zimbabwe to begin an oral cholera vaccination campaign yesterday, in efforts to immunize 1.4 million people living in high-risk regions in Harare, the capital of Zimbabwe.
Zika vaccine yields promising results for treating glioblastoma
An international team of researchers have successfully deployed a Zika virus vaccine to target and kill human glioblastoma brain cancer stem cells, which had been transplanted into mice.
Broadly neutralizing antibodies: is production influenced by HIV’s genome?
A recent study carried out by researchers from the University of Zurich and University Hospital Zurich has discovered that the production of broad acting antibodies is dependent on the genome of the virus.
Record high for measles cases in European Region
In the first 6 months of 2018 over 41, 000 children and adults in the WHO European Region have been infected with measles; more than the annual total of any year since 2010.
Rotavirus vaccination has reduced infant deaths in Malawi by a third
The first population-level evidence has proved the rotavirus vaccination saves lives in low-income settings.
Ebola vaccination initiated in North Kivu
Vaccination has begun to try and contain the second outbreak of Ebola seen in the Democratic Republic of Congo this year.
Can the human microbiome influence rotavirus vaccine response?
New study finds that the oral rotavirus vaccine response could be influenced by changes in the human microbiota.
UK committee recommends HPV vaccinations for adolescent boys
The Joint Committee on Vaccination and Immunisation has stated that a gender-neutral vaccine program would be cost effective in the UK and would protect boys against HPV infection and associated diseases.
